PIK3CA and lymphoma: ,58, 59, 60, 61, 62, 63 Previous studies have also examined inhibitors of PI3K, AKT, and mTOR signaling in canine tumors, including hemangiosarcoma, lymphoma, mast cell tumor, melanoma, mammary gland tumor, and OS.20